ArticleJournal of clinical medicine2026
Long-Term Response Without Immune-Related Adverse Events to Atezolizumab Treatment in TMB-High Thymoma: A Case Report from the KOSMOS-II Study.
In Hee Lee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.